Legal Opinion
King Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.
District Court, D. New Jersey
Decided January 20, 2006No. Civil Action 05-3855 (JAP)PublishedCited by 2 opinions
1Opinion of the Court
OPINION
PISANO, District Judge.
I. INTRODUCTION
Plaintiffs King Pharmaceuticals, Inc. (“King Pharma”) and King Pharmaceuticals Research and Development, Inc. (“King R & D”) (together, “King”), as well as involuntary Plaintiff Wyeth, 1 brought this action for patent infringement against Defendant Teva Pharmaceuticals USA, Inc. (“Teva”). King alleges that Teva has infringed one or more claims of United States Patent No. 4,626,538 (“the '538 Patent”), owned by Wyeth, under which King R & D has exclusive license and King Pharma exclusive sub-license to sell zaleplon drug products in the United…
2Cases cited26 opinions
- Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1984
- Hishon v. King & SpaldingSupreme Court of the United States · 1984
- Skidmore v. Swift & Co.Supreme Court of the United States · 1944
- Hughes Aircraft Co. v. JacobsonSupreme Court of the United States · 1999
- Key Tronic Corp. v. United StatesSupreme Court of the United States · 1994
21 more not listed; retrieve them via the Exa API.
3Cited by2 opinions
- Merck & Co. v. Hi-Tech Pharmacal Co.Court of Appeals for the Federal Circuit · 2007
- Merck & Co. v. Hi-Tech Pharmacal Co.Court of Appeals for the Federal Circuit · 2007